Editorial: Admission for rheumatoid arthritis

September 1974
British Medical Journal;9/28/1974, Vol. 3 Issue 5934, p759
Academic Journal
No abstract available.


Related Articles

  • Rheumatoid arthritis: ultrastructure of the synovium. Grimley, Philip M.; Grimley, P M // Annals of Internal Medicine;Mar67, Vol. 66 Issue 3, p623 

    Editorial. Focuses on the ultrastructure of the synovium in rheumatoid arthritis. Information on the synovial lining cells in rheumatoid arthritis; Nature of rheumatoid arthritis; Fibroblasts of the synovial lining.

  • Time to abandon the rheumatoid factor? Is it not time to rename it? SHABAN, R.; HULL, R. // Rheumatology;Oct2007, Vol. 46 Issue 10, p1627 

    A letter to the editor is presented in response to an editorial by D. P. Symmons about rheumatoid factor and rheumatoid arthritis in a 2007 issue.

  • Minocycline treatment of rheumatoid arthritis. Paulus, Harold E. // Annals of Internal Medicine;1/15/95, Vol. 122 Issue 2, p147 

    Editorial. Discusses the side effects of minocycline, which is used for the treatment of rheumatoid arthritis. Dosage for minocycline; Indications and contraindications; Microorganisms responsible for arthritis.

  • Rheumatoid arthritis.  // GP: General Practitioner;5/27/2002, p73 

    Presents a clinical review of rheumatoid arthritis. Epidemiology of rheumatoid arthritis; Therapeutics for rheumatoid arthritis; Causal factor of rheumatoid arthritis.

  • Apheresis and Rheumatoid Arthritis. Decker, John L. // Annals of Internal Medicine;May83 Part 1, Vol. 98 Issue 5, p666 

    Editorial. Talks about the development of remedies in interrupting the pain and inflammation of rheumatoid arthritis. Mechanical modalities that relieve pain in rheumatoid arthritis; Information on the method of plasmapheresis; Description of the leukapheresis procedure.

  • Methotrexate Treatment of Rheumatoid Arthritis. Willkens, Robert F. // Annals of Internal Medicine;Oct85, Vol. 103 Issue 4, p612 

    Editorial. Deals with the effectiveness of methotrexate treatment of rheumatoid arthritis. Limited toxicity of the drug; Long-term dermatologic effect of the methotrexate; Other agents used for the treatment of rheumatoid arthritis.

  • Disease modifying drugs in rheumatoid arthritis. Wollheim, Frank A. // BMJ: British Medical Journal (International Edition);3/15/97, Vol. 314 Issue 7083, p766 

    Editorial. Examines the effectiveness of disease modifying drugs in rheumatoid arthritis. Symptomatology of rheumatoid arthritis; Support for early aggressive treatment based on results of an open randomized study of very early cases in the Netherlands; Appropriateness of early aggressive...

  • Excitement--and confusion--about HLA and rheumatoid arthritis. Harris Jr., Edward D. // Annals of Internal Medicine;8/1/95, Vol. 123 Issue 3, p232 

    Editorial. Focuses on the debate about the relationship between rheumatoid arthritis and the HLA genes of the major histocompatibility complex (MHC) in the United States. Previous studies on rheumatoid arthritis; Function of the MHC; Racial predisposition; Prevalence.

  • Retinoid therapy for rheumatoid arthritis. Harris Jr., Edward D.; Harris, E D Jr // Annals of Internal Medicine;Jan84, Vol. 100 Issue 1, p146 

    Editorial. Focuses on the use of retinoids for the treatment of rheumatoid arthritis. Rheumatoid synovial tissue in organ culture; Rheumatoid synovial cells in monolayer culture; Inhibition of production of collagenase by rabbit fibroblasts.

  • Rheumatoid Arthritis. Walling, Anne D. // American Family Physician;3/15/1999, Vol. 59 Issue 6, p1679 

    Focuses on rheumatoid arthritis. Information on the symptoms of rheumatoid arthritis; Distinction between rheumatoid arthritis and degenerative arthritis; Treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics